Microglial cell activation in aging and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 2, 1997, Pages 143-149

  Dipatre, Pier Luigi ^a   Gelman, Benjamin B ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Aging; Alzheimer disease; Hippocampus; Microglial cell; Neurofibrillary tangle

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MICROGLIA; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0003176673     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199702000-00004     Document Type: Article

References (41)

1. Perry G, Smith MA. Senile plaques and neurofibrillary tangles: What role do they play in Alzheimer's disease? Clin Neurosci 1993;1:199-203
2. McGeer PL, Walker DG, Akiyama H, Yasuhara O, McGeer EG. Involvement of microglia in Alzheimer's disease. Neuropathol Appl Neurobiol 1994;20:191-92
3. Kalaria RN. Cerebral microvasculature and immunological factors in Alzheimer's disease. Clin Neurosci 1993;1:204-11
4. Masliah E, Mallory M, Hansen L, et al. Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol 1991;83:12-20
5. Carpenter AF, Carpenter, PW, Markesbery WR. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol 1993;52:601-8
6. McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987;79:195-200
7. Mattiace LA, Davies P, Dickson DW. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 1990;136:1101-14
8. Tooyama T, Kimura H, Aiyama H, McGeer PL. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res 1990;523:273-80
9. Styren SD, Civin WH, Rogers J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp Neurol 1990;110:93-104
10. Perlmutter LS, Scott SA, Barron E, Chui HC. MHC class II-positive microglia in human brain: Association with Alzheimer lesions. J Neurosci Res 1902;33:549-58
11. Johnson SA, Lampert-Etchells M, Pasinetti GM, Rpzovsky I, Finch CE. Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning. Neurobiol Aging 1992;13:641-48
12. Griffin WST, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 1995;54:276-81
13. Jellinger K, Paulus W, Grunke-Iqbal I, Riederer P, Youdim MB. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect 1990;2:237-40
14. Grundke-Ikbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol 1990;81:105-10
15. Ohgami T, Kitamoto T, Shin RW, Kaneko Y, Ogomori K, Tateishi J. Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathol 1991;81:242-47
16. Miyazono M, Iwaki T, Kitamoto T, Kaneko Y, Doh-ura K, Tateishi J. A comparative immunohistochemical study of kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol 1991;139:589-98
17. Connor JR, Menzies SL, St Martin SM, Mufson EJ. A histochemical study of iron, transferrin and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992;31:75-83
18. Gelman BB. Iron in CNS disease. J Neuropathol Exp Neurol 1995;54:477-86
19. Roe MT, Dawson DV, Hulette CM, Einstein G, Grain BJ. Microglia are not exclusively associated with plaque-rich regions of the dentate gyrus in Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:366-71
20. McGeer PL, McGeer EG. Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann NY Acad Sci 1996;777:213-20
21. Cras P, Kawai M, Siedlak S, et al. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol 1990;137:241-46
22. Goodwin JL, Uemura E, Cunnick JE. Microglial cell release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. Brain Res 1995;692:207-14
23. Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995;374:647-50
24. Braak H, Braak E. Neuropathological staging of Alzheimer's disease changes. Acta Neuropathol 191;82:239-59
25. Samuel W, Masliah E, Hill LR, Butters N, Terry R. Hippocampal connectivity and Alzheimer's dementia: Effects of synapse loss and tangle frequency in a two component model. Neurology 1994;44: 2081-88
26. DiPatre PL, Gelman BB. Hippocampal microglial cell activation is not correlated with plaque and tangle densities in Alzheimer's disease. Lab Invest 1995;72:135A
27. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 1993;117:132-34
28. Gelman BB, Rodriguez-Wolf MG, Wen J, Kumar S, Campbell GA, Herzog N. Siderotic cerebral macrophages in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1992;116:509-16
29. Gelman BB. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol 1993;34: 65-70
30. Sevier AC, Munger BL. A silver method for paraffin section of neural tissue. J Neuropathol Exp Neurol 1965;24:130-35
31. Remington RD, Schork MA. Statistics with applications to the biological and health sciences. Englewood Cliffs: Prentice-Hall, 1970:253-81
32. Darlington RB. Regression and linear models. New York: McGrawHill, 1990
33. Arriagada PV, Marzloff, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern of Alzheimer's disease. Ann Neurol 1992;42:1681-88
34. Dickson DE, Mattiace LA, Kure K, et al. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 1991;64:135-56
35. Arriagada PV, Growdon JH, Hedley-White ET, Hyman BT Neurofibrillary tangles but not senile plaques parallel the duration and severity of Alzheimer's disease. Neurology 1992;42:631-39
36. Cras P, Kawai M, Siedlak S, Perry G. Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease. Brain Res 1991;558:312-14
37. Ikeda K, Akyiama H, Haga C, Haga S. Evidence that neurofibrillary tangles undergo glial modification. Acta Neuropathol 1992;85:101-4
38. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo. Science 1988;239:290-92
39. Harr SD, Simonian NA, Hyman BT. Functional alterations in Alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J Neuropathol Exp Neurol 1995;54:38-41
40. Hyman BT, Van Hoesen GW, Kromer LT, Damasio AR. Perforant pathway changes and the memory impairment in Alzheimer's disease. Ann Neurol 1986;20:472-81
41. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80